Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

ClinicalTrials.gov ID: NCT00683436

Public ClinicalTrials.gov record NCT00683436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Blinded, Active and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This will be a multi-center, randomized, blinded, comparative, placebo-controlled, 4 arm crossover study in patients with primary insomnia.

Study identification

NCT ID
NCT00683436
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neurogen Corporation
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Sep 30, 2008
Completion
Oct 31, 2008
Last update posted
Jul 21, 2008

2008

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Broward Research Group Pembroke Pines Florida 33026
Miami Research Associates South Miami Florida 33143
Neurotrials Research, Inc Atlanta Georgia 30342
Sleep and Behavior Medicine Institute Vernon Hills Illinois 60061
Vince & Associates Clinical Research Overland Park Kansas 66212
St. Luke's Hospital Sleep Medicine and Research Center Chesterfield Missouri 63017
Clinilabs, Inc. New York New York 10019
Tri-State Sleep Disorders Center Cincinnati Ohio 45246
Lynn Health Science Institute Oklahoma City Oklahoma 73112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00683436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2008 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00683436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →